beta

OREX

Orexigen Therapeutics Inc.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Orexigen Therapeutics Inc is an emerging pharmaceutical company. The company is developing neuroscience drugs that will ultimately address obesity and weight related medical issues.

Market Cap: 20.8 Million

Primary Exchange: Nasdaq Global Select

Website: http://www.orexigen.com

Shares Outstanding: 18.7 Million

Float: 18.4 Million

Dividend: 0.0 (0.0%)

Beta: 2.048594

Sector: Healthcare

Industry: Drug Manufacturers

Ethical Flags

Longest drawdown: 790 trading days

From: 2015-03-04 To: 2018-04-03

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
2016-07-12 10.0 1.0 10.0
Data provided by IEX Cloud